Company Overview of Endocube
Endocube uses cellular genomics technology to research on endothelium cell biology and the inflammation cascade. Endocube researches to cure disease such as asthma, diabetes and rheumatoid arthritis. The company plans to start selling its own products after it finished its research program. The company was formed in May 2001 by François Amalric, Jean-Philippe Girard and Pierre Bougnères.
Prologue I - La Pyreneenne
Founded in 2001
33 5 62 88 42 50
33 5 62 88 42 51
Key Executives for Endocube
Similar Private Companies By Industry
|Biologie et Industrie SAS||Europe|
|Pherecydes Pharma SA||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Endocube, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.